OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 66 filers reported holding OLEMA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112,828,279 | +64.2% | 9,135,893 | +20.0% | 3.04% | +58.8% |
| Q2 2023 | $68,731,872 | +160.2% | 7,611,503 | 0.0% | 1.92% | +98.5% |
| Q1 2023 | $26,411,915 | +41.6% | 7,611,503 | 0.0% | 0.96% | +22.6% |
| Q4 2022 | $18,648,182 | -11.2% | 7,611,503 | 0.0% | 0.79% | -9.3% |
| Q3 2022 | $21,008,000 | -32.2% | 7,611,503 | 0.0% | 0.87% | -42.0% |
| Q2 2022 | $30,979,000 | -1.9% | 7,611,503 | +2.7% | 1.50% | +18.4% |
| Q1 2022 | $31,573,000 | -54.5% | 7,411,503 | 0.0% | 1.26% | -49.8% |
| Q4 2021 | $69,372,000 | -62.2% | 7,411,503 | +11.3% | 2.52% | -64.8% |
| Q3 2021 | $183,591,000 | -1.5% | 6,661,503 | 0.0% | 7.16% | +2.5% |
| Q2 2021 | $186,389,000 | -15.7% | 6,661,503 | 0.0% | 6.99% | -15.7% |
| Q1 2021 | $221,029,000 | -31.0% | 6,661,503 | 0.0% | 8.29% | -34.2% |
| Q4 2020 | $320,285,000 | – | 6,661,503 | – | 12.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $15,238,000 | 2.80% |
| Fairmount Funds Management LLC | 2,669,300 | $10,864,000 | 2.49% |
| BVF INC/IL | 7,611,503 | $30,979,000 | 1.50% |
| Vivo Capital, LLC | 1,689,515 | $6,876,000 | 0.69% |
| Cormorant Asset Management, LP | 2,082,000 | $8,474,000 | 0.64% |
| Newtyn Management, LLC | 500,000 | $2,035,000 | 0.39% |
| Kynam Capital Management, LP | 249,229 | $1,014,000 | 0.26% |
| Monaco Asset Management SAM | 130,000 | $529,000 | 0.23% |
| TANG CAPITAL MANAGEMENT LLC | 318,926 | $1,298,000 | 0.20% |
| Artal Group S.A. | 260,500 | $1,060,000 | 0.06% |